GlaxoSmithKline LLC, Durham, North Carolina, was awarded a $279,862,800 firm-fixed-price contract for procurement, storage, and distribution of GlaxoSmithKline’s monoclonal antibody therapeutic treatment Sotrovimab. Bids were solicited via the internet with one received. Work will be performed in Durham, North Carolina, with an estimated completion date of May 19, 2022. Fiscal 2021 Defense Production Act purchases, defense funds in the amount of $279,862,800 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W58P05-21-C-0008). (Awarded Sept. 29, 2021)